Today, Cell Genesis is thrilled to announce the launch of CEXCI Cord Protein Banking, a groundbreaking initiative that marks a new era in the field of stem cell research and personalized medicine. This innovative approach harnesses the power of umbilical cord stem cells protein to unlock a world of possibilities for improved health outcomes and transformative medical treatments.
Cord Protein Banking represents a paradigm shift in the utilization of the umbilical cord, which has long been recognized for its rich source of valuable stem cells. However, recent scientific advancements have revealed that the umbilical cord is not only a reservoir of stem cells but also contains a wide array of precious proteins with remarkable therapeutic potential.
Through Cell Genesis’s state-of-the-art technology and cutting-edge laboratory processes, Dr. Michael Lim Ming Soon, the founder of Cell Genesis, has developed a proprietary method to extract and preserve these cord proteins, ensuring their long-term stability and potency. This pioneering technique facilitates creation of a comprehensive catalogue of cord proteins, which can be accessed on demand for various medical applications.
The applications of Cord Protein Banking are vast and diverse. These proteins hold immense promise in the fields of regenerative medicine, precision oncology, cardiovascular and neurological disorders, to name just a few. By banking cord proteins, individuals and healthcare professionals gain access to an extensive library of bioactive substances that can be used for therapeutic interventions tailored to each patient’s unique needs.
One of the key advantages of Cord Protein Banking is its compatibility with existing cord blood banking services. Families who have already chosen to bank their newborn’s cord blood can now opt to enhance their investment by including the preservation of cord proteins. This ensures they are not only preserving the potential for future stem cell therapies but also securing a wealth of additional therapeutic options through cord proteins.
Cell Genesis is committed to driving scientific advancements and pioneering research in the field of cord protein applications. Their team of renowned scientists, medical experts, and industry leaders works tirelessly to unlock the full potential of cord proteins and revolutionize the way healthcare is approached.
To learn more about CEXCI Cord Protein Banking and how it can empower the future of personalized medicine, please visit our website CEXCI.
About Cell Genesis:
Cell Genesis is a leading biotechnology company dedicated to advancing the frontiers of science and medicine. We specialize in innovative research, development, and commercialization of cutting-edge technologies aimed at transforming healthcare and improving patient outcomes. With a strong focus on stem cell science, we are committed to pushing boundaries, driving discoveries, and bringing revolutionary therapies to the forefront of modern medicine.
For more information, please visit the official website https://cellgenesis.com.my
For media inquiries, please contact:
Dr. Michael Lim Ming Soon
admin@cellgenesis.co
+60 3-7622 2991
